CYTARABINE

CYTARABINE was reported 60759 times

CYTARABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 148 0.9673
1 THYMUS HYPOPLASIA 151 0.8678
2 HUMAN BOCAVIRUS INFECTION 133 0.7037
3 CYTARABINE SYNDROME 39 0.5132
4 GEOTRICHUM INFECTION 80 0.3791
5 STOMATOCOCCAL INFECTION 41 0.3306
6 CYSTITIS BACTERIAL 110 0.3254
7 NOROVIRUS TEST POSITIVE 104 0.3200
8 MANTLE CELL LYMPHOMA RECURRENT 126 0.2897
9 CAECITIS 124 0.2756
10 HEPATOSPLENIC CANDIDIASIS 39 0.2653
11 ACUTE MONOCYTIC LEUKAEMIA 47 0.2582
12 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 235 0.2482
13 MYCOBACTERIUM CHELONAE INFECTION 179 0.2422
14 DISSEMINATED ASPERGILLOSIS 110 0.2331
15 ACUTE MYELOID LEUKAEMIA RECURRENT 497 0.2313
16 CONGENITAL APLASIA 71 0.2283
17 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 502 0.2275
18 RETINOIC ACID SYNDROME 39 0.2267
19 SECONDARY IMMUNODEFICIENCY 263 0.2165
20 ABSCESS BACTERIAL 76 0.2094
21 FUSARIUM INFECTION 145 0.2071
22 ENTEROVIRUS TEST POSITIVE 34 0.1954
23 MALIGNANT TRANSFORMATION 86 0.1915
24 NEUTROPENIC COLITIS 388 0.1874
25 ANTITHROMBIN III DECREASED 48 0.1758
26 FEBRILE BONE MARROW APLASIA 742 0.1744
27 HYPOFIBRINOGENAEMIA 170 0.1714
28 PSEUDOMONAL SEPSIS 298 0.1700
29 TREATMENT RELATED SECONDARY MALIGNANCY 34 0.1675
30 CENTRAL HYPOTHYROIDISM 55 0.1662
31 CHLOROMA 70 0.1659
32 BLOOD STEM CELL TRANSPLANT FAILURE 35 0.1628
33 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 37 0.1595
34 MYELOPATHY 300 0.1578
35 CORONA VIRUS INFECTION 67 0.1558
36 LEUKAEMIA RECURRENT 263 0.1554
37 PARAINFLUENZAE VIRUS INFECTION 235 0.1543
38 T-CELL TYPE ACUTE LEUKAEMIA 31 0.1520
39 APLASIA 290 0.1480
40 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 134 0.1449
41 VENOOCCLUSIVE LIVER DISEASE 707 0.1430
42 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 364 0.1409
43 BLOOD CULTURE POSITIVE 417 0.1391
44 TRICHOSPORON INFECTION 55 0.1358
45 B-CELL LYMPHOMA RECURRENT 72 0.1326
46 CENTRAL NERVOUS SYSTEM LEUKAEMIA 52 0.1323
47 ARACHNOIDITIS 91 0.1315
48 HUMAN HERPESVIRUS 6 INFECTION 244 0.1290
49 PYOMYOSITIS 38 0.1284
50 VENOOCCLUSIVE DISEASE 321 0.1281
51 ENTEROBACTER INFECTION 213 0.1266
52 ASPERGILLUS TEST POSITIVE 38 0.1234
53 LOWER RESPIRATORY TRACT INFECTION FUNGAL 47 0.1208
54 CEREBRAL FUNGAL INFECTION 34 0.1201
55 FEBRILE NEUTROPENIA 7783 0.1172
56 SYSTEMIC MYCOSIS 136 0.1164
57 FUNGAEMIA 181 0.1149
58 GLIOMA 73 0.1135
59 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 37 0.1128
60 BACILLUS INFECTION 71 0.1123
61 CYTOMEGALOVIRUS CHORIORETINITIS 218 0.1117
62 KLEBSIELLA SEPSIS 120 0.1065
63 MINIMAL RESIDUAL DISEASE 51 0.1056
64 ESCHERICHIA BACTERAEMIA 247 0.1050
65 ZYGOMYCOSIS 49 0.1047
66 HUMAN RHINOVIRUS TEST POSITIVE 39 0.1046
67 ENGRAFT FAILURE 30 0.1045
68 VIRAL HAEMORRHAGIC CYSTITIS 74 0.1039
69 ENGRAFTMENT SYNDROME 61 0.1032
70 CYSTITIS VIRAL 38 0.0992
71 LEUKOENCEPHALOPATHY 369 0.0990
72 CENTRAL NERVOUS SYSTEM LYMPHOMA 136 0.0986
73 ENTEROCOCCAL BACTERAEMIA 104 0.0981
74 NEUTROPENIC INFECTION 93 0.0972
75 CANDIDA PNEUMONIA 31 0.0960
76 BRONCHOPULMONARY ASPERGILLOSIS 741 0.0955
77 MANTLE CELL LYMPHOMA 143 0.0939
78 PNEUMONIA FUNGAL 370 0.0937
79 STREPTOCOCCAL BACTERAEMIA 100 0.0919
80 ENTEROBACTER SEPSIS 34 0.0919
81 VIRAEMIA 127 0.0916
82 BLAST CELLS PRESENT 44 0.0915
83 STENOTROPHOMONAS INFECTION 124 0.0914
84 ENTEROCOCCUS TEST POSITIVE 59 0.0910
85 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 59 0.0899
86 VASOGENIC CEREBRAL OEDEMA 64 0.0889
87 GRANULOCYTE COUNT DECREASED 164 0.0884
88 MUCORMYCOSIS 228 0.0877
89 PSEUDOMONAL BACTERAEMIA 74 0.0867
90 CENTRAL LINE INFECTION 32 0.0865
91 MYELODYSPLASTIC SYNDROME TRANSFORMATION 45 0.0864
92 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 237 0.0857
93 ACUTE MYELOID LEUKAEMIA 1332 0.0854
94 BLOOD FIBRINOGEN DECREASED 97 0.0849
95 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 61 0.0848
96 SINUSITIS FUNGAL 67 0.0835
97 FOLLICULAR LYMPHOMA 73 0.0830
98 CANDIDA SEPSIS 74 0.0825
99 MYELOID LEUKAEMIA 41 0.0818
100 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 38 0.0815
101 SUPERIOR SAGITTAL SINUS THROMBOSIS 65 0.0814
102 HAEMATOTOXICITY 771 0.0811
103 SYSTEMIC CANDIDA 203 0.0808
104 METASTASES TO SPLEEN 33 0.0799
105 B PRECURSOR TYPE ACUTE LEUKAEMIA 31 0.0799
106 KLEBSIELLA TEST POSITIVE 52 0.0799
107 DIFFUSE ALVEOLAR DAMAGE 91 0.0791
108 PSEUDOMONAS TEST POSITIVE 64 0.0781
109 ASPERGILLUS INFECTION 508 0.0773
110 BACTERIAL SEPSIS 252 0.0773
111 ESCHERICHIA SEPSIS 224 0.0772
112 ACUTE PROMYELOCYTIC LEUKAEMIA 79 0.0768
113 DIFFERENTIATION SYNDROME 56 0.0763
114 ASPERGILLOSIS 97 0.0742
115 METASTASES TO BONE MARROW 37 0.0740
116 ENTEROCOCCAL INFECTION 355 0.0734
117 ENCEPHALITIS CYTOMEGALOVIRUS 32 0.0731
118 ENTEROCOCCAL SEPSIS 59 0.0728
119 ACUTE LYMPHOCYTIC LEUKAEMIA 206 0.0727
120 FUNGAL SEPSIS 60 0.0722
121 RESPIRATORY TRACT INFECTION FUNGAL 38 0.0720
122 STREPTOCOCCAL SEPSIS 84 0.0708
123 SCEDOSPORIUM INFECTION 50 0.0708
124 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 100 0.0708
125 MUCOSAL INFLAMMATION 1846 0.0704
126 NEOPLASM RECURRENCE 235 0.0692
127 TUMOUR LYSIS SYNDROME 605 0.0687
128 DIFFUSE LARGE B-CELL LYMPHOMA 529 0.0686
129 CYTOMEGALOVIRUS VIRAEMIA 304 0.0683
130 STEROID DIABETES 102 0.0680
131 NEUTROPENIC SEPSIS 483 0.0676
132 MYELOSUPPRESSION 2421 0.0671
133 GRAFT VERSUS HOST DISEASE IN LIVER 48 0.0670
134 ENTEROVIRUS INFECTION 57 0.0660
135 PNEUMATOSIS INTESTINALIS 186 0.0651
136 GRAFT VERSUS HOST DISEASE IN SKIN 143 0.0649
137 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 138 0.0648
138 MYELODYSPLASTIC SYNDROME 915 0.0632
139 KLEBSIELLA BACTERAEMIA 60 0.0632
140 RHINOVIRUS INFECTION 246 0.0631
141 ESCHERICHIA TEST POSITIVE 75 0.0626
142 ACUTE GRAFT VERSUS HOST DISEASE 284 0.0620
143 BONE MARROW FAILURE 1245 0.0612
144 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 79 0.0600
145 B-CELL TYPE ACUTE LEUKAEMIA 44 0.0599
146 CYTOMEGALOVIRUS INFECTION REACTIVATION 264 0.0597
147 DRUG CLEARANCE DECREASED 78 0.0597
148 STEM CELL TRANSPLANT 146 0.0584
149 STAPHYLOCOCCAL BACTERAEMIA 253 0.0581
150 FEBRILE INFECTION 68 0.0578
151 BLOOD LACTATE DEHYDROGENASE ABNORMAL 39 0.0575
152 CYSTITIS HAEMORRHAGIC 231 0.0572
153 GLIOBLASTOMA MULTIFORME 48 0.0570
154 CEREBRAL TOXOPLASMOSIS 53 0.0567
155 SEPTIC EMBOLUS 47 0.0565
156 PERIPHERAL MOTOR NEUROPATHY 79 0.0563
157 ENTEROCOLITIS INFECTIOUS 52 0.0563
158 CLOSTRIDIUM DIFFICILE COLITIS 586 0.0552
159 PULMONARY MYCOSIS 43 0.0552
160 GRAFT VERSUS HOST DISEASE 395 0.0549
161 CHRONIC GRAFT VERSUS HOST DISEASE 198 0.0548
162 HYPERBILIRUBINAEMIA 567 0.0547
163 STAPHYLOCOCCAL SEPSIS 269 0.0544
164 CAPILLARY LEAK SYNDROME 112 0.0541
165 BACTERAEMIA 640 0.0539
166 EPSTEIN-BARR VIRAEMIA 59 0.0532
167 CONTINUOUS HAEMODIAFILTRATION 51 0.0521
168 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 495 0.0518
169 SECOND PRIMARY MALIGNANCY 425 0.0510
170 ADENOVIRUS INFECTION 148 0.0510
171 HYPERTRIGLYCERIDAEMIA 298 0.0509
172 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 47 0.0508
173 PHILADELPHIA CHROMOSOME POSITIVE 36 0.0492
174 PNEUMONIA KLEBSIELLA 90 0.0489
175 GASTROENTERITIS NOROVIRUS 65 0.0489
176 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 38 0.0486
177 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 183 0.0479
178 INFECTION IN AN IMMUNOCOMPROMISED HOST 34 0.0474
179 PNEUMONIA CYTOMEGALOVIRAL 91 0.0468
180 HYPOGAMMAGLOBULINAEMIA 307 0.0467
181 WHITE MATTER LESION 58 0.0459
182 CLOSTRIDIUM TEST POSITIVE 100 0.0453
183 JC VIRUS INFECTION 72 0.0450
184 BLAST CELL COUNT INCREASED 47 0.0448
185 CYTOPENIA 546 0.0445
186 KLEBSIELLA INFECTION 225 0.0444
187 CATHETER RELATED INFECTION 45 0.0444
188 HISTIOCYTOSIS HAEMATOPHAGIC 131 0.0441
189 TOXIC LEUKOENCEPHALOPATHY 32 0.0441
190 SEPTIC SHOCK 1909 0.0438
191 SOFT TISSUE INFECTION 80 0.0437
192 CSF PROTEIN INCREASED 35 0.0422
193 PHARYNGEAL INFLAMMATION 51 0.0419
194 PLATELET TRANSFUSION 54 0.0419
195 NEUROTOXICITY 733 0.0418
196 HYPERLEUKOCYTOSIS 37 0.0418
197 BACTERIAL INFECTION 770 0.0412
198 TRANSFUSION REACTION 36 0.0410
199 CEREBELLAR SYNDROME 90 0.0410
200 INTUSSUSCEPTION 39 0.0408
201 DEVICE RELATED THROMBOSIS 40 0.0406
202 PULMONARY HAEMORRHAGE 313 0.0400
203 VENOUS THROMBOSIS 157 0.0400
204 BONE MARROW DEPRESSION 39 0.0400
205 CYTOGENETIC ABNORMALITY 45 0.0399
206 CULTURE POSITIVE 33 0.0395
207 PANCYTOPENIA 2200 0.0393
208 CEREBRAL VENOUS SINUS THROMBOSIS 33 0.0391
209 GENE MUTATION 77 0.0389
210 PROCALCITONIN INCREASED 45 0.0383
211 PSEUDOMONAS INFECTION 329 0.0383
212 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 32 0.0380
213 QUADRIPARESIS 63 0.0379
214 ENTERITIS 240 0.0375
215 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 222 0.0374
216 BK VIRUS INFECTION 124 0.0367
217 ESCHERICHIA INFECTION 302 0.0367
218 CLOSTRIDIUM COLITIS 44 0.0362
219 PERIRECTAL ABSCESS 40 0.0361
220 PARAPLEGIA 104 0.0360
221 HERPES SIMPLEX 231 0.0355
222 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 180 0.0353
223 CYTOKINE RELEASE SYNDROME 703 0.0350
224 MENINGITIS BACTERIAL 50 0.0349
225 CENTRAL NERVOUS SYSTEM INFECTION 40 0.0349
226 ENTEROCOLITIS 200 0.0346
227 STAPHYLOCOCCUS TEST POSITIVE 72 0.0341
228 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 42 0.0340
229 OESOPHAGEAL CANDIDIASIS 135 0.0338
230 CARDIOTOXICITY 301 0.0337
231 GASTROINTESTINAL TOXICITY 161 0.0335
232 INFECTION REACTIVATION 38 0.0332
233 PARAPARESIS 59 0.0331
234 LUNG CONSOLIDATION 92 0.0329
235 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 58 0.0328
236 JUGULAR VEIN THROMBOSIS 58 0.0326
237 SUBCLAVIAN VEIN THROMBOSIS 37 0.0325
238 LUNG INFILTRATION 287 0.0325
239 HEPATITIS B REACTIVATION 103 0.0324
240 TOXOPLASMOSIS 35 0.0324
241 BLOOD LACTATE DEHYDROGENASE INCREASED 513 0.0323
242 HEPATOSPLENOMEGALY 82 0.0319
243 VENA CAVA THROMBOSIS 53 0.0319
244 SKIN TOXICITY 180 0.0318
245 MULTIPLE ORGAN DYSFUNCTION SYNDROME 881 0.0311
246 MULTIPLE-DRUG RESISTANCE 96 0.0309
247 APLASTIC ANAEMIA 161 0.0308
248 HYPOALBUMINAEMIA 239 0.0307
249 NEUROLOGICAL DECOMPENSATION 71 0.0307
250 CYTOMEGALOVIRUS INFECTION 507 0.0305
251 EPSTEIN-BARR VIRUS INFECTION 190 0.0304
252 HEPATITIS E 48 0.0304
253 ACINETOBACTER INFECTION 33 0.0301
254 DYSPLASIA 36 0.0300
255 ACUTE RESPIRATORY DISTRESS SYNDROME 529 0.0299
256 BONE MARROW DISORDER 90 0.0298
257 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 222 0.0296
258 GASTROINTESTINAL WALL THICKENING 44 0.0294
259 AREFLEXIA 78 0.0292
260 CEREBRAL VENOUS THROMBOSIS 53 0.0292
261 CYTOMEGALOVIRUS TEST POSITIVE 52 0.0291
262 QUADRIPLEGIA 60 0.0291
263 BRAIN HERNIATION 87 0.0291
264 HAEMATOLOGICAL INFECTION 71 0.0290
265 INTRACRANIAL VENOUS SINUS THROMBOSIS 31 0.0289
266 GASTROINTESTINAL NECROSIS 83 0.0284
267 BILIRUBIN CONJUGATED INCREASED 66 0.0282
268 CULTURE URINE POSITIVE 39 0.0277
269 NEUTROPENIA 3744 0.0275
270 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 63 0.0271
271 THROMBOCYTOPENIA 3005 0.0268
272 SEPSIS 2989 0.0268
273 MULTI-ORGAN FAILURE 458 0.0265
274 BACTERIAL TEST POSITIVE 59 0.0264
275 DISSEMINATED INTRAVASCULAR COAGULATION 370 0.0263
276 ACUTE LEUKAEMIA 42 0.0260
277 PERIPHERAL SENSORY NEUROPATHY 151 0.0258
278 ENCEPHALITIS 178 0.0257
279 PNEUMOCYSTIS JIROVECII PNEUMONIA 258 0.0257
280 PUPIL FIXED 44 0.0254
281 BONE MARROW TRANSPLANT 48 0.0253
282 NEUTROPHIL COUNT DECREASED 1030 0.0252
283 CYTOMEGALOVIRUS COLITIS 58 0.0252
284 THERAPY PARTIAL RESPONDER 389 0.0249
285 DEVICE RELATED SEPSIS 50 0.0248
286 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 203 0.0246
287 NEPHROPATHY TOXIC 276 0.0246
288 MYELITIS 38 0.0245
289 HEPATOTOXICITY 545 0.0245
290 BRAIN ABSCESS 61 0.0241
291 LEFT VENTRICULAR DYSFUNCTION 161 0.0240
292 BLOOD BILIRUBIN INCREASED 642 0.0237
293 METASTASES TO MENINGES 54 0.0237
294 HYPOPROTEINAEMIA 45 0.0237
295 DISEASE PROGRESSION 2800 0.0236
296 OBLITERATIVE BRONCHIOLITIS 31 0.0236
297 GUILLAIN-BARRE SYNDROME 114 0.0235
298 LYMPHOPENIA 329 0.0232
299 MEGACOLON 36 0.0229
300 PNEUMONIA PSEUDOMONAL 35 0.0228
301 CLOSTRIDIAL INFECTION 77 0.0227
302 VARICELLA ZOSTER VIRUS INFECTION 47 0.0227
303 FUNGAL INFECTION 754 0.0226
304 VENTRICULAR HYPOKINESIA 72 0.0224
305 OTOTOXICITY 41 0.0222
306 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 32 0.0220
307 PULMONARY ALVEOLAR HAEMORRHAGE 123 0.0219
308 AGRANULOCYTOSIS 405 0.0218
309 DEVICE RELATED INFECTION 330 0.0214
310 HYPERPHOSPHATAEMIA 46 0.0214
311 SPINAL CORD DISORDER 35 0.0213
312 CANDIDA INFECTION 347 0.0205
313 HYPERPYREXIA 86 0.0203
314 LYMPHOMA 312 0.0202
315 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 102 0.0201
316 ENCEPHALOPATHY 491 0.0200
317 HAEMODYNAMIC INSTABILITY 152 0.0199
318 ILEUS PARALYTIC 89 0.0199
319 COLITIS 748 0.0197
320 B-CELL LYMPHOMA 66 0.0194
321 RADICULOPATHY 51 0.0193
322 MULTI-ORGAN DISORDER 38 0.0193
323 ATELECTASIS 186 0.0192
324 INTRACARDIAC THROMBUS 59 0.0192
325 PATHOGEN RESISTANCE 174 0.0191
326 INTRACRANIAL PRESSURE INCREASED 105 0.0188
327 HEPATITIS B 113 0.0187
328 CANDIDIASIS 75 0.0187
329 HEPATOMEGALY 182 0.0185
330 PNEUMOCYSTIS JIROVECI PNEUMONIA 41 0.0184
331 NEUTROPHIL COUNT ABNORMAL 52 0.0184
332 RECURRENT CANCER 73 0.0179
333 LUNG OPACITY 47 0.0178
334 NEOPLASM PROGRESSION 618 0.0178
335 HYPOREFLEXIA 34 0.0177
336 BLOOD HIV RNA INCREASED 32 0.0176
337 RESPIRATORY FAILURE 1283 0.0176
338 PNEUMONIA VIRAL 56 0.0175
339 HYPOXIA 616 0.0175
340 HAEMOGLOBIN ABNORMAL 112 0.0174
341 HAEMODIALYSIS 146 0.0174
342 NECROTISING FASCIITIS 61 0.0173
343 RESPIRATORY DISTRESS 477 0.0173
344 LIVER ABSCESS 56 0.0172
345 EJECTION FRACTION DECREASED 268 0.0172
346 THROMBOTIC MICROANGIOPATHY 167 0.0171
347 LUNG NEOPLASM 73 0.0171
348 HYDROCEPHALUS 93 0.0171
349 ATYPICAL PNEUMONIA 51 0.0170
350 STAPHYLOCOCCAL INFECTION 561 0.0170
351 TACHYPNOEA 231 0.0170
352 CARDIOMYOPATHY 248 0.0168
353 COAGULOPATHY 278 0.0167
354 MONOPARESIS 30 0.0166
355 HEPATIC LESION 71 0.0164
356 CARDIAC DYSFUNCTION 61 0.0164
357 ACIDOSIS 125 0.0163
358 TRANSPLANT FAILURE 40 0.0163
359 PLATELET COUNT DECREASED 1739 0.0163
360 GRANULOCYTOPENIA 92 0.0161
361 HYPERURICAEMIA 66 0.0160
362 ILEUS 197 0.0158
363 STREPTOCOCCAL INFECTION 88 0.0158
364 LYMPHOCYTOSIS 34 0.0158
365 LIPASE INCREASED 121 0.0158
366 PULSE ABSENT 75 0.0158
367 SUBDURAL HAEMORRHAGE 43 0.0157
368 POLYNEUROPATHY 188 0.0157
369 PETECHIAE 163 0.0156
370 RETINAL HAEMORRHAGE 111 0.0156
371 INTRA-ABDOMINAL HAEMORRHAGE 37 0.0155
372 PLATELET DISORDER 39 0.0155
373 DRUG RESISTANCE 396 0.0154
374 SUBILEUS 32 0.0154
375 HYPOPHOSPHATAEMIA 113 0.0153
376 SINUS TACHYCARDIA 216 0.0152
377 APPENDICITIS 142 0.0152
378 LEUKOPENIA 758 0.0151
379 LUNG INFECTION 232 0.0149
380 ABDOMINAL INFECTION 38 0.0149
381 PARESIS 33 0.0148
382 BLOOD LACTIC ACID INCREASED 78 0.0148
383 PANCREATITIS NECROTISING 34 0.0148
384 HAEMORRHAGE INTRACRANIAL 220 0.0147
385 HYPERNATRAEMIA 73 0.0146
386 COMPUTERISED TOMOGRAM ABNORMAL 33 0.0146
387 PLATELET COUNT ABNORMAL 88 0.0145
388 NEUROLOGICAL SYMPTOM 83 0.0145
389 CYTOLYTIC HEPATITIS 48 0.0144
390 PLEURAL EFFUSION 873 0.0143
391 CHRONIC MYELOID LEUKAEMIA 66 0.0143
392 PNEUMONIA BACTERIAL 131 0.0143
393 MENINGITIS ASEPTIC 64 0.0142
394 BLOOD ALBUMIN DECREASED 113 0.0142
395 WHITE BLOOD CELL DISORDER 38 0.0142
396 TRANSAMINASES INCREASED 315 0.0142
397 CARDIAC TAMPONADE 67 0.0141
398 NECROSIS 78 0.0140
399 ALANINE AMINOTRANSFERASE INCREASED 855 0.0139
400 METHAEMOGLOBINAEMIA 32 0.0138
401 HYPERAMMONAEMIA 69 0.0138
402 BRAIN OEDEMA 173 0.0137
403 ASCITES 402 0.0137
404 TOXIC ENCEPHALOPATHY 69 0.0136
405 MYELOFIBROSIS 41 0.0135
406 ORGANISING PNEUMONIA 67 0.0135
407 HEPATOCELLULAR INJURY 190 0.0134
408 PROTHROMBIN TIME PROLONGED 80 0.0134
409 ACUTE PULMONARY OEDEMA 75 0.0133
410 PERICARDIAL EFFUSION 308 0.0133
411 WHITE BLOOD CELL COUNT ABNORMAL 85 0.0133
412 PULMONARY TOXICITY 94 0.0133
413 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 136 0.0132
414 CARDIAC FAILURE ACUTE 88 0.0132
415 INFECTION 1897 0.0131
416 HYPERTRANSAMINASAEMIA 91 0.0131
417 SUBDURAL HAEMATOMA 187 0.0131
418 ELECTROLYTE IMBALANCE 151 0.0130
419 PORTAL HYPERTENSION 40 0.0130
420 STOMATITIS 786 0.0129
421 SUBARACHNOID HAEMORRHAGE 131 0.0128
422 PAPILLOEDEMA 58 0.0128
423 HEMIPARESIS 217 0.0128
424 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 34 0.0128
425 MENINGITIS 85 0.0127
426 ENDOCARDITIS 65 0.0127
427 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 63 0.0126
428 HEPATIC FAILURE 379 0.0126
429 OLIGURIA 78 0.0126
430 SERUM FERRITIN INCREASED 66 0.0125
431 HYPOKALAEMIA 577 0.0125
432 ATAXIA 148 0.0125
433 TACHYARRHYTHMIA 31 0.0124
434 LYMPHADENITIS 30 0.0124
435 WHITE BLOOD CELL COUNT DECREASED 1342 0.0124
436 ASPARTATE AMINOTRANSFERASE INCREASED 657 0.0124
437 PYREXIA 4271 0.0123
438 AUTOIMMUNE HAEMOLYTIC ANAEMIA 42 0.0122
439 AMYLASE INCREASED 45 0.0122
440 CHOLESTASIS 233 0.0121
441 GASTROINTESTINAL INFLAMMATION 95 0.0121
442 CARDIOPULMONARY FAILURE 47 0.0120
443 METABOLIC DISORDER 70 0.0120
444 EMBOLISM 100 0.0120
445 ABDOMINAL MASS 32 0.0119
446 HYPOVOLAEMIC SHOCK 57 0.0119
447 HYDRONEPHROSIS 89 0.0119
448 FIBRIN D DIMER INCREASED 42 0.0118
449 OTITIS MEDIA 39 0.0118
450 LEUKAEMIA 111 0.0118
451 GAMMA-GLUTAMYLTRANSFERASE INCREASED 257 0.0116
452 NO THERAPEUTIC RESPONSE 141 0.0116
453 ANAL ABSCESS 62 0.0115
454 RESPIRATORY SYNCYTIAL VIRUS INFECTION 100 0.0115
455 VASCULAR DEVICE INFECTION 52 0.0115
456 HEPATITIS FULMINANT 34 0.0114
457 ARTHRITIS BACTERIAL 47 0.0114
458 ELECTROENCEPHALOGRAM ABNORMAL 36 0.0114
459 LYMPHADENOPATHY 402 0.0113
460 BRAIN DEATH 35 0.0113
461 FACIAL PARESIS 40 0.0113
462 HAEMORRHAGE SUBCUTANEOUS 40 0.0113
463 FLUID OVERLOAD 164 0.0113
464 ACUTE RESPIRATORY FAILURE 215 0.0112
465 THERAPY NON-RESPONDER 500 0.0111
466 ANURIA 95 0.0110
467 IMMUNOSUPPRESSION 97 0.0110
468 DISEASE RECURRENCE 521 0.0109
469 VIRAL INFECTION 364 0.0109
470 HERPES VIRUS INFECTION 63 0.0109
471 SPLENOMEGALY 128 0.0109
472 CEREBRAL ISCHAEMIA 56 0.0109
473 EMBOLISM VENOUS 33 0.0109
474 SUSPECTED OFF LABEL USE 49 0.0108
475 ESCHERICHIA URINARY TRACT INFECTION 46 0.0108
476 MENTAL STATUS CHANGES 300 0.0108
477 CHEST X-RAY ABNORMAL 33 0.0108
478 TORSADE DE POINTES 84 0.0107
479 HYPERGLYCAEMIA 386 0.0106
480 CONGESTIVE CARDIOMYOPATHY 44 0.0105
481 HEPATIC FUNCTION ABNORMAL 389 0.0104
482 CHRONIC SINUSITIS 39 0.0104
483 CLOSTRIDIUM DIFFICILE INFECTION 226 0.0103
484 INTESTINAL ISCHAEMIA 57 0.0103
485 FACIAL PARALYSIS 87 0.0102
486 LEFT VENTRICULAR FAILURE 35 0.0102
487 COVID-19 PNEUMONIA 120 0.0102
488 CEREBRAL ATROPHY 40 0.0100
489 DRUG TOXICITY 136 0.0100
490 DRUG-INDUCED LIVER INJURY 313 0.0100
491 ANAEMIA 1894 0.0099
492 JAUNDICE CHOLESTATIC 35 0.0099
493 ABSCESS LIMB 42 0.0098
494 VIITH NERVE PARALYSIS 34 0.0098
495 HYPOCALCAEMIA 185 0.0098
496 LYMPHOCYTE COUNT DECREASED 172 0.0097
497 HEPATIC CYTOLYSIS 124 0.0097
498 GENERALISED OEDEMA 120 0.0097
499 CHOLECYSTITIS 115 0.0096
500 PROCTALGIA 62 0.0096
501 RASH MACULO-PAPULAR 214 0.0096
502 CEREBRAL HAEMORRHAGE 344 0.0096
503 CELLULITIS 484 0.0096
504 HYPOVOLAEMIA 56 0.0096
505 PANCREATITIS ACUTE 215 0.0096
506 PROTEIN TOTAL DECREASED 36 0.0096
507 MOUTH HAEMORRHAGE 70 0.0095
508 PULMONARY OEDEMA 426 0.0095
509 PULMONARY MASS 140 0.0094
510 ADRENAL INSUFFICIENCY 114 0.0094
511 NERVOUS SYSTEM DISORDER 292 0.0093
512 TOXIC EPIDERMAL NECROLYSIS 141 0.0093
513 RENAL FAILURE ACUTE 393 0.0093
514 DERMATITIS BULLOUS 67 0.0092
515 CATHETER SITE INFECTION 35 0.0092
516 FOETAL GROWTH RESTRICTION 56 0.0092
517 MALIGNANT NEOPLASM PROGRESSION 941 0.0092
518 TACHYCARDIA 811 0.0091
519 HYPERVOLAEMIA 45 0.0091
520 INFLAMMATORY MARKER INCREASED 45 0.0091
521 URINE OUTPUT DECREASED 79 0.0090
522 MYOSITIS 81 0.0090
523 ORAL HERPES 173 0.0089
524 ABDOMINAL TENDERNESS 44 0.0089
525 DIALYSIS 125 0.0088
526 FLUID INTAKE REDUCED 44 0.0088
527 MONOPLEGIA 38 0.0087
528 SHOCK HAEMORRHAGIC 71 0.0087
529 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 203 0.0087
530 METASTASIS 62 0.0087
531 ECCHYMOSIS 59 0.0086
532 BODY TEMPERATURE INCREASED 175 0.0086
533 INTESTINAL PERFORATION 96 0.0085
534 TOXIC SKIN ERUPTION 86 0.0085
535 LOWER GASTROINTESTINAL HAEMORRHAGE 63 0.0085
536 HAEMOGLOBIN DECREASED 874 0.0085
537 C-REACTIVE PROTEIN INCREASED 308 0.0085
538 ACUTE HEPATIC FAILURE 115 0.0084
539 LARGE INTESTINE PERFORATION 58 0.0083
540 LIVER INJURY 203 0.0083
541 ACUTE KIDNEY INJURY 1259 0.0082
542 RESPIRATORY RATE INCREASED 73 0.0082
543 FUNGAL SKIN INFECTION 33 0.0082
544 RENAL TUBULAR NECROSIS 80 0.0081
545 SHOCK 187 0.0081
546 LEUKOCYTOSIS 147 0.0081
547 PNEUMONITIS 221 0.0081
548 NEUROPATHY PERIPHERAL 770 0.0081
549 BLOOD URIC ACID INCREASED 46 0.0080
550 HEPATIC NECROSIS 30 0.0080
551 CHOLECYSTITIS ACUTE 45 0.0079
552 PULSELESS ELECTRICAL ACTIVITY 33 0.0079
553 DISEASE COMPLICATION 36 0.0079
554 TEMPERATURE INTOLERANCE 81 0.0078
555 VENTRICULAR FIBRILLATION 87 0.0078
556 HYPOMAGNESAEMIA 109 0.0078
557 OSTEONECROSIS 257 0.0078
558 PURPURA 69 0.0078
559 DERMATITIS EXFOLIATIVE 39 0.0078
560 STATUS EPILEPTICUS 88 0.0078
561 MALNUTRITION 87 0.0078
562 UNRESPONSIVE TO STIMULI 200 0.0077
563 HEPATIC STEATOSIS 144 0.0077
564 CACHEXIA 39 0.0076
565 CARDIOGENIC SHOCK 108 0.0075
566 SMALL INTESTINAL OBSTRUCTION 92 0.0075
567 CORONAVIRUS INFECTION 49 0.0074
568 HYPOTENSION 1486 0.0074
569 PNEUMONIA 2390 0.0074
570 HYPERTHERMIA 56 0.0073
571 FAECAL INCONTINENCE 35 0.0073
572 TRANSFUSION 76 0.0072
573 PRODUCT USE IN UNAPPROVED INDICATION 1793 0.0072
574 VENTRICULAR TACHYCARDIA 119 0.0072
575 ODYNOPHAGIA 43 0.0072
576 FULL BLOOD COUNT DECREASED 145 0.0072
577 HYPOPHAGIA 183 0.0072
578 SUPRAVENTRICULAR TACHYCARDIA 68 0.0071
579 CENTRAL NERVOUS SYSTEM LESION 96 0.0070
580 HEMIPLEGIA 58 0.0070
581 HEPATIC ENCEPHALOPATHY 65 0.0070
582 HEPATITIS ACUTE 45 0.0069
583 HIDRADENITIS 63 0.0069
584 PANCREATITIS 365 0.0069
585 AMMONIA INCREASED 35 0.0069
586 NEPHROTIC SYNDROME 47 0.0068
587 BLOOD CREATININE INCREASED 446 0.0068
588 DRUG ERUPTION 121 0.0068
589 LOW BIRTH WEIGHT BABY 54 0.0068
590 BLOOD CREATINE INCREASED 30 0.0068
591 OESOPHAGITIS 74 0.0068
592 HYPERCALCAEMIA 83 0.0067
593 ELECTROCARDIOGRAM QT PROLONGED 240 0.0067
594 GRAND MAL CONVULSION 61 0.0066
595 CARDIAC FAILURE 528 0.0066
596 BLOOD UREA INCREASED 110 0.0066
597 SKIN NECROSIS 34 0.0065
598 HICCUPS 53 0.0065
599 ORAL DISORDER 47 0.0064
600 BLOOD ALKALINE PHOSPHATASE INCREASED 158 0.0064
601 RESPIRATORY DISORDER 190 0.0063
602 GENERALISED TONIC-CLONIC SEIZURE 105 0.0063
603 RENAL FAILURE 842 0.0063
604 SENSORY LOSS 51 0.0063
605 IMMUNODEFICIENCY 94 0.0063
606 APHASIA 190 0.0063
607 JAUNDICE 169 0.0063
608 PERICARDITIS 105 0.0062
609 GASTROINTESTINAL INFECTION 56 0.0062
610 RALES 36 0.0062
611 PARTIAL SEIZURES 32 0.0061
612 BRAIN NEOPLASM 56 0.0061
613 DYSARTHRIA 229 0.0061
614 SKIN INFECTION 68 0.0061
615 CARDIO-RESPIRATORY ARREST 253 0.0060
616 MYOPATHY 52 0.0060
617 MYOCARDITIS 69 0.0060
618 ATRIAL FLUTTER 48 0.0060
619 NEOPLASM 69 0.0060
620 OFF LABEL USE 5221 0.0060
621 HAEMATOCRIT DECREASED 118 0.0059
622 CARDIAC ARREST 491 0.0059
623 TONSILLITIS 31 0.0059
624 PNEUMOTHORAX 94 0.0059
625 TROPONIN INCREASED 45 0.0059
626 HYPONATRAEMIA 333 0.0059
627 APNOEA 46 0.0059
628 ANGIOPATHY 33 0.0059
629 NYSTAGMUS 31 0.0058
630 PERONEAL NERVE PALSY 33 0.0058
631 TRICUSPID VALVE INCOMPETENCE 46 0.0058
632 HAEMOLYSIS 44 0.0057
633 ORAL CANDIDIASIS 75 0.0057
634 SINUS BRADYCARDIA 55 0.0057
635 VENTRICULAR EXTRASYSTOLES 59 0.0057
636 BLOOD DISORDER 45 0.0056
637 RESPIRATORY TRACT INFECTION 146 0.0056
638 HEPATITIS 142 0.0055
639 PAPULE 39 0.0055
640 REFUSAL OF TREATMENT BY PATIENT 36 0.0055
641 HAEMATURIA 188 0.0055
642 HEPATITIS CHOLESTATIC 33 0.0055
643 DIARRHOEA HAEMORRHAGIC 51 0.0055
644 SKIN LESION 149 0.0054
645 MITRAL VALVE INCOMPETENCE 61 0.0054
646 METABOLIC ACIDOSIS 172 0.0054
647 CHILLS 630 0.0054
648 DEPRESSED LEVEL OF CONSCIOUSNESS 211 0.0053
649 MOUTH ULCERATION 112 0.0053
650 ANOREXIA 68 0.0053
651 EYE MOVEMENT DISORDER 36 0.0053
652 DERMATITIS ALLERGIC 66 0.0052
653 SKIN MASS 35 0.0052
654 NEUTROPHIL COUNT INCREASED 53 0.0052
655 ENDOPHTHALMITIS 31 0.0052
656 RENAL IMPAIRMENT 434 0.0052
657 PREMATURE DELIVERY 82 0.0051
658 MOTOR DYSFUNCTION 52 0.0051
659 BLOOD CALCIUM DECREASED 57 0.0051
660 TOXICITY TO VARIOUS AGENTS 848 0.0050
661 HAEMOLYTIC ANAEMIA 45 0.0050
662 HAEMOPTYSIS 139 0.0050
663 DRUG LEVEL INCREASED 81 0.0049
664 ABSCESS 78 0.0049
665 UPPER GASTROINTESTINAL HAEMORRHAGE 82 0.0049
666 RASH ERYTHEMATOUS 231 0.0048
667 OEDEMA 262 0.0048
668 ATRIAL FIBRILLATION 463 0.0047
669 GENERAL PHYSICAL HEALTH DETERIORATION 541 0.0047
670 GASTROINTESTINAL HAEMORRHAGE 390 0.0047
671 CEREBRAL INFARCTION 114 0.0047
672 EYELID PTOSIS 47 0.0046
673 PARALYSIS 66 0.0046
674 RED BLOOD CELL COUNT DECREASED 131 0.0046
675 INTENTIONAL PRODUCT USE ISSUE 401 0.0046
676 HAEMATEMESIS 116 0.0046
677 LIVER FUNCTION TEST ABNORMAL 133 0.0046
678 ALTERED STATE OF CONSCIOUSNESS 99 0.0046
679 ANAL INCONTINENCE 41 0.0046
680 WHITE BLOOD CELL COUNT INCREASED 174 0.0045
681 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 247 0.0045
682 CONVULSION 256 0.0045
683 LIVER DISORDER 198 0.0045
684 HYPOTHERMIA 45 0.0044
685 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 76 0.0044
686 ABDOMINAL PAIN 1027 0.0044
687 MELAENA 97 0.0044
688 CIRCULATORY COLLAPSE 75 0.0044
689 TUBULOINTERSTITIAL NEPHRITIS 82 0.0044
690 PLATELET COUNT INCREASED 57 0.0044
691 BRADYCARDIA 231 0.0044
692 PREMATURE BABY 131 0.0043
693 TREATMENT FAILURE 357 0.0043
694 CARDIOMEGALY 53 0.0043
695 PROCEDURAL COMPLICATION 33 0.0043
696 DRUG INTERACTION 676 0.0043
697 RASH PUSTULAR 31 0.0043
698 HERPES ZOSTER 241 0.0042
699 DEEP VEIN THROMBOSIS 272 0.0042
700 INTERSTITIAL LUNG DISEASE 202 0.0042
701 PYELONEPHRITIS 36 0.0042
702 PALLOR 113 0.0041
703 SEIZURE 478 0.0041
704 HYPERLIPIDAEMIA 49 0.0041
705 BLOOD TRIGLYCERIDES INCREASED 72 0.0041
706 SUDDEN DEATH 43 0.0041
707 DECUBITUS ULCER 33 0.0040
708 OXYGEN SATURATION DECREASED 227 0.0040
709 EPISTAXIS 302 0.0040
710 HYPOTONIA 40 0.0040
711 BRAIN INJURY 40 0.0040
712 BASAL CELL CARCINOMA 62 0.0040
713 PULMONARY EMBOLISM 375 0.0039
714 TOOTH ABSCESS 40 0.0039
715 ASPIRATION 43 0.0039
716 FACE OEDEMA 66 0.0039
717 METASTASES TO CENTRAL NERVOUS SYSTEM 50 0.0039
718 EPILEPSY 118 0.0039
719 ELECTROCARDIOGRAM ABNORMAL 30 0.0038
720 LUNG DISORDER 187 0.0038
721 PERITONITIS 79 0.0038
722 URINARY INCONTINENCE 113 0.0038
723 VOMITING 1775 0.0038
724 GLOMERULAR FILTRATION RATE DECREASED 46 0.0037
725 BLINDNESS 152 0.0037
726 STEVENS-JOHNSON SYNDROME 82 0.0037
727 COVID-19 642 0.0037
728 ERYTHEMA MULTIFORME 34 0.0036
729 PROTEINURIA 69 0.0036
730 SQUAMOUS CELL CARCINOMA 34 0.0036
731 PULMONARY HYPERTENSION 75 0.0036
732 LACTIC ACIDOSIS 116 0.0036
733 DISORIENTATION 141 0.0036
734 DIPLOPIA 92 0.0035
735 DELIRIUM 122 0.0035
736 MYOCARDIAL ISCHAEMIA 40 0.0035
737 OSTEOMYELITIS 63 0.0035
738 ISCHAEMIC STROKE 61 0.0034
739 INCONTINENCE 36 0.0034
740 METASTASES TO LUNG 39 0.0034
741 CYSTITIS 107 0.0034
742 HEPATIC ENZYME INCREASED 229 0.0034
743 URINARY RETENTION 111 0.0033
744 HAEMORRHAGE 347 0.0033
745 GASTRIC HAEMORRHAGE 38 0.0033
746 PHOTOPHOBIA 62 0.0033
747 GASTROENTERITIS 48 0.0033
748 VASCULITIS 38 0.0033
749 ORAL PAIN 73 0.0033
750 MUSCULAR WEAKNESS 369 0.0032
751 METASTASES TO LIVER 56 0.0032
752 NEURALGIA 77 0.0032
753 BLOOD POTASSIUM DECREASED 95 0.0032
754 GASTROINTESTINAL DISORDER 280 0.0031
755 GINGIVAL BLEEDING 42 0.0031
756 PULMONARY FIBROSIS 59 0.0031
757 UPPER RESPIRATORY TRACT INFECTION 142 0.0031
758 GASTRITIS 80 0.0030
759 PULMONARY CONGESTION 40 0.0030
760 BLOOD SODIUM DECREASED 57 0.0030
761 NODULE 39 0.0030
762 BLOOD PRESSURE DECREASED 197 0.0030
763 COMA 140 0.0029
764 MASS 41 0.0029
765 INTERNATIONAL NORMALISED RATIO INCREASED 83 0.0029
766 PHARYNGITIS 36 0.0029
767 SENSORY DISTURBANCE 46 0.0029
768 HYPERKALAEMIA 100 0.0028
769 PRODUCT USE ISSUE 532 0.0028
770 ORTHOSTATIC HYPOTENSION 49 0.0028
771 IMMUNE SYSTEM DISORDER 37 0.0028
772 TOOTH INFECTION 37 0.0028
773 ANAPHYLACTIC REACTION 155 0.0028
774 DIARRHOEA 1805 0.0028
775 INFUSION RELATED REACTION 185 0.0028
776 HAEMATOMA 72 0.0028
777 CONJUNCTIVITIS 51 0.0027
778 CYANOSIS 43 0.0027
779 ABDOMINAL DISTENSION 285 0.0027
780 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 194 0.0027
781 RESPIRATORY ARREST 75 0.0027
782 HAEMORRHOIDS 53 0.0027
783 FEEDING DISORDER 55 0.0027
784 DYSPNOEA EXERTIONAL 102 0.0027
785 LIVER FUNCTION TEST INCREASED 58 0.0027
786 BONE PAIN 158 0.0027
787 BRONCHOSPASM 38 0.0027
788 HEPATIC CIRRHOSIS 50 0.0027
789 DRUG INTOLERANCE 255 0.0026
790 HYPERTENSION 557 0.0026
791 INTESTINAL OBSTRUCTION 99 0.0026
792 DYSPHAGIA 249 0.0026
793 CHOLELITHIASIS 86 0.0026
794 INFLAMMATION 135 0.0026
795 ILL-DEFINED DISORDER 157 0.0026
796 MYDRIASIS 33 0.0026
797 DEAFNESS 67 0.0026
798 DECREASED APPETITE 594 0.0026
799 ACUTE MYOCARDIAL INFARCTION 74 0.0025
800 SARS-COV-2 TEST POSITIVE 33 0.0025
801 PULMONARY ARTERIAL HYPERTENSION 36 0.0025
802 PRODUCT PRESCRIBING ISSUE 54 0.0025
803 CONFUSIONAL STATE 400 0.0025
804 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 63 0.0024
805 THERAPEUTIC RESPONSE DECREASED 148 0.0024
806 DRUG INEFFECTIVE 3207 0.0024
807 ARRHYTHMIA 114 0.0024
808 DEATH 2066 0.0024
809 NAUSEA 1896 0.0024
810 DEHYDRATION 317 0.0024
811 PNEUMONIA ASPIRATION 59 0.0024
812 COGNITIVE DISORDER 110 0.0024
813 PRESYNCOPE 57 0.0023
814 OEDEMA PERIPHERAL 277 0.0023
815 MUSCULOSKELETAL CHEST PAIN 35 0.0023
816 RENAL INJURY 67 0.0023
817 PRODUCTIVE COUGH 107 0.0022
818 RASH PAPULAR 50 0.0022
819 LETHARGY 128 0.0022
820 ASTHENIA 825 0.0022
821 POST PROCEDURAL COMPLICATION 42 0.0022
822 BLOOD COUNT ABNORMAL 33 0.0022
823 DRUG EFFECT INCOMPLETE 79 0.0022
824 DYSURIA 80 0.0022
825 HYPOGLYCAEMIA 105 0.0022
826 COUGH 605 0.0022
827 RECTAL HAEMORRHAGE 92 0.0021
828 HALLUCINATION, VISUAL 45 0.0021
829 DERMATITIS 44 0.0021
830 BLOOD POTASSIUM INCREASED 34 0.0021
831 SYNCOPE 206 0.0021
832 ANAPHYLACTIC SHOCK 53 0.0021
833 CONDITION AGGRAVATED 613 0.0020
834 ULCER 32 0.0020
835 DIVERTICULITIS 55 0.0020
836 CARDIAC FAILURE CONGESTIVE 159 0.0020
837 SKIN DISORDER 66 0.0020
838 HEART RATE INCREASED 196 0.0020
839 ABDOMINAL PAIN LOWER 50 0.0020
840 RENAL DISORDER 92 0.0020
841 AGITATION 145 0.0020
842 RASH PRURITIC 107 0.0020
843 THROMBOSIS 158 0.0020
844 RASH 854 0.0020
845 FAECES DISCOLOURED 42 0.0019
846 RHINORRHOEA 124 0.0019
847 HAEMATOCHEZIA 104 0.0019
848 SEROTONIN SYNDROME 36 0.0019
849 OROPHARYNGEAL PAIN 172 0.0019
850 SINUSITIS 190 0.0019
851 CONSTIPATION 391 0.0018
852 VISUAL ACUITY REDUCED 59 0.0018
853 BLOOD CREATINE PHOSPHOKINASE INCREASED 51 0.0018
854 OSTEONECROSIS OF JAW 43 0.0017
855 HEADACHE 1083 0.0017
856 PLASMA CELL MYELOMA 67 0.0017
857 DYSPNOEA 964 0.0017
858 RETCHING 36 0.0017
859 URINARY TRACT INFECTION 282 0.0017
860 MATERNAL EXPOSURE DURING PREGNANCY 147 0.0016
861 EATING DISORDER 35 0.0016
862 BACK PAIN 378 0.0016
863 LABORATORY TEST ABNORMAL 48 0.0016
864 ERYTHEMA 328 0.0016
865 PSYCHOTIC DISORDER 47 0.0016
866 NIGHT SWEATS 51 0.0016
867 RHABDOMYOLYSIS 66 0.0016
868 MUSCULOSKELETAL DISORDER 30 0.0016
869 HYPOAESTHESIA 233 0.0016
870 PARAESTHESIA 243 0.0015
871 CHEST PAIN 285 0.0015
872 FLUID RETENTION 78 0.0015
873 FOETAL EXPOSURE DURING PREGNANCY 122 0.0015
874 ANGIOEDEMA 65 0.0015
875 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 43 0.0015
876 LOSS OF CONSCIOUSNESS 188 0.0015
877 CARDIOVASCULAR DISORDER 37 0.0015
878 PAIN IN JAW 41 0.0014
879 HYPOTHYROIDISM 46 0.0014
880 EXPOSURE DURING PREGNANCY 85 0.0014
881 MENTAL IMPAIRMENT 33 0.0014
882 VAGINAL HAEMORRHAGE 59 0.0014
883 SKIN ULCER 35 0.0014
884 CHEST DISCOMFORT 137 0.0013
885 DYSKINESIA 54 0.0013
886 INFLUENZA 148 0.0013
887 SPEECH DISORDER 69 0.0013
888 OESOPHAGEAL CARCINOMA 39 0.0013
889 TYPE 2 DIABETES MELLITUS 43 0.0013
890 SKIN EXFOLIATION 107 0.0013
891 CEREBROVASCULAR ACCIDENT 214 0.0013
892 GAIT DISTURBANCE 237 0.0012
893 RASH GENERALISED 32 0.0012
894 TRANSIENT ISCHAEMIC ATTACK 41 0.0012
895 PAIN IN EXTREMITY 356 0.0012
896 DRUG EXPOSURE DURING PREGNANCY 41 0.0012
897 HYPERSENSITIVITY 220 0.0012
898 GASTRIC CANCER 30 0.0012
899 NEOPLASM MALIGNANT 78 0.0012
900 NECK PAIN 65 0.0012
901 RASH MACULAR 40 0.0011
902 HEAD INJURY 36 0.0011
903 DYSSTASIA 33 0.0011
904 MYALGIA 191 0.0011
905 GAIT INABILITY 37 0.0011
906 IMPAIRED HEALING 36 0.0011
907 CARDIAC DISORDER 102 0.0011
908 WEIGHT DECREASED 303 0.0011
909 HEART RATE DECREASED 38 0.0011
910 SOMNOLENCE 217 0.0011
911 PRURITUS 410 0.0011
912 TREMOR 175 0.0011
913 DISCOMFORT 63 0.0010
914 EYE PAIN 58 0.0010
915 CORONARY ARTERY DISEASE 31 0.0010
916 FATIGUE 787 0.0010
917 HYPERHIDROSIS 130 0.0010
918 HALLUCINATION 76 0.0010
919 NEPHROLITHIASIS 46 0.0010
920 BLISTER 56 0.0010
921 DIABETES MELLITUS 76 0.0010
922 FLUSHING 100 0.0010
923 BALANCE DISORDER 85 0.0010
924 WEIGHT INCREASED 217 0.0010
925 SWELLING FACE 63 0.0010
926 VISION BLURRED 132 0.0010
927 MEDICATION ERROR 52 0.0009
928 EYE DISORDER 30 0.0009
929 DYSGEUSIA 67 0.0009
930 RESTLESSNESS 33 0.0009
931 DRY EYE 45 0.0009
932 IRRITABILITY 54 0.0009
933 ADVERSE EVENT 82 0.0009
934 BLOOD CHOLESTEROL INCREASED 41 0.0009
935 OSTEOPOROSIS 36 0.0009
936 PALPITATIONS 102 0.0009
937 TINNITUS 40 0.0009
938 BRONCHITIS 64 0.0009
939 MUSCULOSKELETAL PAIN 44 0.0008
940 DISTURBANCE IN ATTENTION 45 0.0008
941 ABDOMINAL PAIN UPPER 171 0.0008
942 SKIN DISCOLOURATION 38 0.0008
943 MOBILITY DECREASED 59 0.0008
944 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
945 NO ADVERSE EVENT 144 0.0008
946 SWELLING 73 0.0008
947 CONTUSION 74 0.0008
948 POLLAKIURIA 32 0.0008
949 PAIN 469 0.0008
950 MENTAL DISORDER 33 0.0008
951 ABNORMAL BEHAVIOUR 30 0.0008
952 TREATMENT NONCOMPLIANCE 41 0.0007
953 NASAL CONGESTION 44 0.0007
954 DIZZINESS 367 0.0007
955 MYOCARDIAL INFARCTION 123 0.0007
956 FALL 231 0.0007
957 CHRONIC KIDNEY DISEASE 52 0.0007
958 WHEEZING 40 0.0007
959 MALAISE 295 0.0007
960 VISUAL IMPAIRMENT 83 0.0007
961 DRUG EFFECT DECREASED 35 0.0006
962 THERAPY INTERRUPTED 46 0.0006
963 BLOOD PRESSURE INCREASED 95 0.0006
964 AGGRESSION 31 0.0006
965 BLOOD GLUCOSE INCREASED 115 0.0006
966 ALOPECIA 119 0.0006
967 ARTHRALGIA 246 0.0006
968 URTICARIA 98 0.0006
969 FLATULENCE 32 0.0006
970 DYSPEPSIA 55 0.0006
971 UNEVALUABLE EVENT 42 0.0006
972 AMNESIA 33 0.0005
973 ABDOMINAL DISCOMFORT 83 0.0005
974 ANXIETY 138 0.0005
975 MEMORY IMPAIRMENT 64 0.0005
976 MUSCULOSKELETAL STIFFNESS 40 0.0005
977 DRY MOUTH 35 0.0004
978 DEPRESSION 97 0.0004
979 PROSTATE CANCER 31 0.0004
980 PERIPHERAL SWELLING 50 0.0003
981 HOSPITALISATION 47 0.0003
982 MUSCLE SPASMS 55 0.0003
983 INSOMNIA 71 0.0003
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
985 OVERDOSE 55 0.0003
986 DRY SKIN 33 0.0002
987 NASOPHARYNGITIS 42 0.0002
988 FEELING ABNORMAL 38 0.0002